Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$3.92B |
| 2 |
Visa
V
|
+$551M |
| 3 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$406M |
| 4 |
UnitedHealth
UNH
|
+$395M |
| 5 |
Advanced Micro Devices
AMD
|
+$363M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.41B |
| 2 |
NVIDIA
NVDA
|
+$2.28B |
| 3 |
Microsoft
MSFT
|
+$2.02B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.83B |
| 5 |
Flutter Entertainment
FLUT
|
+$962M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.87% |
| 2 | Consumer Discretionary | 7.14% |
| 3 | Financials | 7.05% |
| 4 | Industrials | 4.81% |
| 5 | Communication Services | 4.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SUNS
4426
Sunrise Realty Trust
SUNS
$106M
| $119K | ﹤0.01% |
8,484
+1,092
| +15% | +$15.8K |
|
4427
Unilever
UL
$137B
| $119K | ﹤0.01% |
1,867
-88
| -5% | -$5.94K |
|
|
CVAC
4428
DELISTED
CureVac
CVAC
| $119K | ﹤0.01% |
34,836
+11,890
| +52% | +$34.3K |
|
4429
Ultrapar
UGP
$6.95B
| $119K | ﹤0.01% |
45,133
+36,700
| +435% | +$122K |
|
4430
XBiotech
XBIT
$68M
| $119K | ﹤0.01% |
30,004
+3,661
| +14% | +$25K |
|
4431
Lineage Cell Therapeutics
LCTX
$269M
| $118K | ﹤0.01% |
234,069
+22,769
| +11% | +$16.7K |
|
4432
VirTra
VTSI
$34.9M
| $117K | ﹤0.01% |
17,275
+2,247
| +15% | +$15.2K |
|
4433
Seer Inc
SEER
$122M
| $116K | ﹤0.01% |
50,424
-14,002
| -22% | -$30.7K |
|
4434
Atomera
ATOM
$200M
| $116K | ﹤0.01% |
+10,000
| New | +$57.6K |
|
4435
inTEST
INTT
$155M
| $116K | ﹤0.01% |
13,473
| – | – |
|
4436
Invesco S&P 500 High Beta ETF
SPHB
$971M
| $115K | ﹤0.01% |
+1,300
| New | +$118K |
|
4437
InnovAge Holding
INNV
$1.54B
| $114K | ﹤0.01% |
29,099
+3,485
| +14% | +$18K |
|
|
DAWN
4438
CALL
DELISTED
Day One Biopharmaceuticals
DAWN
| $114K | ﹤0.01% |
9,000
-21,000
| -70% | -$292K |
|
|
DAWN
4439
PUT
DELISTED
Day One Biopharmaceuticals
DAWN
| $114K | ﹤0.01% |
9,000
-21,000
| -70% | -$292K |
|
4440
Ultralife
ULBI
$86.4M
| $113K | ﹤0.01% |
15,233
+1,838
| +14% | +$15.1K |
|
4441
Invesco Leisure and Entertainment ETF
PEJ
$259M
| $113K | ﹤0.01% |
2,160
| – | – |
|
4442
AbCellera Biologics
ABCL
$1.74B
| $112K | ﹤0.01% |
38,351
+16,058
| +72% | +$44.7K |
|
4443
Bassett Furniture
BSET
$164M
| $112K | ﹤0.01% |
8,076
-2,048
| -20% | -$29.5K |
|
4444
PUT
BRC Group Holdings
RILY
$288M
| $111K | ﹤0.01% |
24,200
| – | – |
|
4445
Fractyl Health
GUTS
$109M
| $109K | ﹤0.01% |
52,926
+5,130
| +11% | +$11.9K |
|
4446
AirSculpt Technologies
AIRS
$339M
| $109K | ﹤0.01% |
20,991
+1,891
| +10% | +$11.6K |
|
|
VIGL
4447
DELISTED
Vigil Neuroscience
VIGL
| $109K | ﹤0.01% |
64,049
+19,436
| +44% | +$57.4K |
|
|
BIOA
4448
BioAge Labs
BIOA
$402M
| $109K | ﹤0.01% |
18,791
+6,891
| +58% | +$119K |
|
4449
ALX Oncology
ALXO
$261M
| $109K | ﹤0.01% |
65,122
+5,620
| +9% | +$8.64K |
|
4450
Greenwich LifeSciences
GLSI
$198M
| $108K | ﹤0.01% |
9,648
+1,088
| +13% | +$14.6K |
|
Similar funds
Barclays's Q4 2024 Portfolio in Review
As of Q4 2024, Barclays held 5,604 positions worth $357B, down 5.3% from $377B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays withdrew a net $28.7B in Q4 2024, closing 348 positions and reducing 1,552 holdings. Its most notable exit was Stericycle Inc, an estimated $97.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Barclays opened a new position in iShares Bitcoin Trust worth $131M.
- Barclays's largest Q4 2024 buy was iShares Bitcoin Trust: 2,473,064 shares worth $131M.
- Barclays added most to Honeywell in Q4 2024, an estimated $3.92B increase.
- Barclays's biggest Q4 2024 reduction was Apple, cutting an estimated $4.41B.
- Barclays fully exited Stericycle Inc in Q4 2024, selling an estimated $97.3M.
- Barclays's ten largest holdings make up 41% of its $357B portfolio in Q4 2024.
- Barclays opened 343 new positions and closed 348 in Q4 2024.
- Barclays's portfolio value fell 5.3% quarter-over-quarter to $357B.
Based on Barclays's 13F filing for Q4 2024, filed 13 Feb 2025.